Maria Maksymowicz
Overview
Explore the profile of Maria Maksymowicz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
311
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tsegaye B, Kober P, Mossakowska B, Baluszek S, Maksymowicz M, Buchalska B, et al.
J Neuroendocrinol
. 2025 Jan;
e13492.
PMID: 39846216
Gonadotroph neuroendocrine pituitary tumors are among the most common intracranial neoplasms. A notable proportion of these tumors is characterized by invasive growth which hampers the treatment results and worsens prognoses...
2.
Jotanovic J, Boldt H, Burton M, Andersen M, Bengtsson D, Bontell T, et al.
Acta Neuropathol
. 2025 Jan;
149(1):4.
PMID: 39747763
No abstract available.
3.
Godlewska-Nowak M, Grochowska A, Zielinski G, Boguslawska A, Adamek D, Maksymowicz M, et al.
Front Endocrinol (Lausanne)
. 2024 Dec;
15:1441745.
PMID: 39640888
Introduction: The T2-signal intensity (SI) of somatotroph pituitary neuroendocrine tumors (sPitNET) is associated with treatment response and granulation pattern. Our aim was to evaluate SI assessment methods and their clinical...
4.
Jotanovic J, Boldt H, Burton M, Andersen M, Bengtsson D, Bontell T, et al.
Acta Neuropathol
. 2024 Nov;
148(1):68.
PMID: 39580368
Aggressive pituitary neuroendocrine tumors (PitNETs)/adenomas are characterized by progressive growth despite surgery and all standard medical therapies and radiotherapy. A subset will metastasize to the brain and/or distant locations and...
5.
Rymuza J, Kober P, Maksymowicz M, Nyc A, Mossakowska B, Woroniecka R, et al.
J Transl Med
. 2024 Nov;
22(1):994.
PMID: 39497133
Background: Somatotroph neuroendocrine pituitary tumors (sPitNET) are a subtype of pituitary tumors that commonly cause acromegaly. Our study aimed to determine the spectrum of DNA copy number abnormalities (CNAs) in...
6.
Dzialach L, Wojciechowska-Luzniak A, Maksymowicz M, Witek P
Front Endocrinol (Lausanne)
. 2024 Jul;
15:1399930.
PMID: 38948516
Ectopic ACTH syndrome (EAS) remains one of the most demanding diagnostic and therapeutic challenges for endocrinologists. Thymic neuroendocrine tumors account for 5%-10% of all EAS cases. We report a unique...
7.
Trofimiuk-Muldner M, Domagala B, Maksymowicz M, Pekul M, Zielinski G, Hubalewska-Dydejczyk A
Pol Arch Intern Med
. 2024 Mar;
134(5).
PMID: 38546339
No abstract available.
8.
Pekul M, Szczepaniak M, Kober P, Rusetska N, Mossakowska B, Baluszek S, et al.
Front Endocrinol (Lausanne)
. 2024 Mar;
15:1302667.
PMID: 38487343
Introduction: Corticotroph pituitary neuroendocrine tumors (PitNETs) develop from ACTH-producing cells. They commonly cause Cushing's disease (CD), however, some remain clinically silent. Recurrent , , and mutations occur in corticotroph PitNETs....
9.
Strzelec M, Jawiarczyk-Przybylowska A, Syrycka J, Zielinski G, Maksymowicz M, Bolanowski M
Pol Arch Intern Med
. 2024 Feb;
134(3).
PMID: 38348816
No abstract available.
10.
Tomasik A, Stelmachowska-Banas M, Maksymowicz M, Czajka-Oraniec I, Raczkiewicz D, Zielinski G, et al.
Biomedicines
. 2023 Dec;
11(12).
PMID: 38137536
The pathologic evaluation of a tumor tissue is an essential part of an acromegaly patient's assessment. This study aimed to analyze the pathologic characteristics of pituitary tumors in patients with...